| 1 |
35005470 | First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations. | 2022 Jan |
2 |
| 2 |
31532756 | Long non-coding RNA TUG1 enhances chemosensitivity in non-small cell lung cancer by impairing microRNA-221-dependent PTEN inhibition. | 2019 Sep 18 |
1 |
| 3 |
31635307 | ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity. | 2019 Oct 18 |
2 |
| 4 |
28342452 | Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer. | 2017 Jan - Mar |
1 |
| 5 |
26695147 | PTEN polymorphisms contribute to clinical outcomes of advanced lung adenocarcinoma patients treated with platinum-based chemotherapy. | 2016 Jun |
3 |
| 6 |
27062783 | [Expression of MiR-130a in Serum Samples of Patients with Epithelial Ovarian Cancer and Its Association with Platinum Resistance]. | 2016 Jan |
2 |
| 7 |
26492315 | Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. | 2015 |
1 |
| 8 |
22901187 | Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. | 2012 |
2 |
| 9 |
20447721 | PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. | 2011 Jan |
1 |
| 10 |
19150122 | Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers. | 2009 Mar |
1 |